RANDAL J KIRK Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for RANDAL J KIRK.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of RANDAL J KIRK. RANDAL J KIRK is Director in CLINICAL DATA INC ($NOVI) and 10% Owner in AmpliPhi Biosciences Corp ($APHB) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in SOLIGENIX, INC. ($DOR) and 10% Owner in Synthetic Biologics, Inc. ($SYN) and 10% Owner in TRANSGENOMIC INC ($TBIO) and Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and 10% Owner in HALOZYME THERAPEUTICS INC ($GYHT) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and 10% Owner in ORAGENICS INC ($OGEN) and 10% Owner in INTREXON CORP ($XON) and Chief Executive Officer in INTREXON CORP ($XON) and Director in INTREXON CORP ($XON) and Executive Chairman in INTREXON CORP ($XON) and 10% Owner in HISTOGENICS CORP ($HSGX) and 10% Owner in AquaBounty Technologies, Inc. ($AQB).

Latest Insider Trading Transactions of RANDAL J KIRK

Sentiment: All, AQB, APHB, NOVI, FCSC, GYHT, HSGX, OGEN, XON, PRPO, SNGX, SYN, ZIOP

Page:   < prev 1 ... 2 3 4 5 6 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.852,250,5941,903,7772,250,594
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.853,8673,2713,867
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.85136,634115,579136,634
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.781,1619011,496,529
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.781,7461,3542,250,594
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.78323,867
Mar 10 2017FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP0.7810682136,634
Mar 02 2017XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,0720108,317
Mar 02 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0720108,317
Mar 02 2017XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GiftG0.0020005,315,4455.3 M to 5.3 M (0.00 %)
Mar 02 2017XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA22.268,984199,9845,315,6455.3 M to 5.3 M (+0.17 %)
Mar 02 2017XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA23.6533,826799,985451,964418.1 K to 452 K (+8.09 %)
Feb 02 2017XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA21.169,451199,9835,306,6615.3 M to 5.3 M (+0.18 %)
Feb 02 2017XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA24.7732,297799,997418,138385.8 K to 418.1 K (+8.37 %)
Feb 02 2017XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,0610107,245
Feb 02 2017ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0610107,245
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.003,63703,6370 to 3.6 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.00199,6820199,6820 to 199.7 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.00338,8160338,8160 to 338.8 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0010,153010,1530 to 10.2 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0020,306020,3060 to 20.3 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0020,306020,3060 to 20.3 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0014,076014,0760 to 14.1 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.003,19903,1990 to 3.2 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0088008800 to 880
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0082,083082,0830 to 82.1 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0099,537099,5370 to 99.5 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0029502950 to 295
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0088508850 to 885
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.001,77001,7700 to 1.8 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.002,02102,0210 to 2 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0012,617012,6170 to 12.6 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.001,13201,1320 to 1.1 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0012,726012,7260 to 12.7 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0010,784010,7840 to 10.8 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.001,70801,7080 to 1.7 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.002,09502,0950 to 2.1 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.002,08002,0800 to 2.1 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.00200200 to 20
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.004,65904,6590 to 4.7 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.0079,288079,2880 to 79.3 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyJ0.005,77505,7750 to 5.8 K
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerBuyP10.332,421,07325,009,6845,161,2472.7 M to 5.2 M (+88.35 %)
Jan 20 2017AQBAquaBounty Technol ...KIRK RANDAL J10% OwnerSellJ0.001,776,55702,740,1744.5 M to 2.7 M (-39.33 %)
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.003,63703,6370 to 3.6 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.00199,6820199,6820 to 199.7 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.00338,8160338,8160 to 338.8 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0010,153010,1530 to 10.2 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0020,306020,3060 to 20.3 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0020,306020,3060 to 20.3 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0014,076014,0760 to 14.1 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.003,19903,1990 to 3.2 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0088008800 to 880
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0082,083082,0830 to 82.1 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0099,537099,5370 to 99.5 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0029502950 to 295
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0088508850 to 885
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.001,77001,7700 to 1.8 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.002,02102,0210 to 2 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0012,617012,6170 to 12.6 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.001,13201,1320 to 1.1 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0012,726012,7260 to 12.7 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0010,784010,7840 to 10.8 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.001,70801,7080 to 1.7 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.002,09502,0950 to 2.1 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.002,08002,0800 to 2.1 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.00200200 to 20
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.004,65904,6590 to 4.7 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.0079,288079,2880 to 79.3 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyJ0.005,77505,7750 to 5.8 K
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP10.332,421,07325,009,6845,161,2472.7 M to 5.2 M (+88.35 %)
Jan 20 2017XONINTREXON CORPKIRK RANDAL J10% OwnerSellJ0.001,776,55702,740,1744.5 M to 2.7 M (-39.33 %)
Dec 30 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0510106,184
Dec 30 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorGrantA0.0017,2040139,513122.3 K to 139.5 K (+14.07 %)
Dec 30 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA24.308,230199,9895,297,2105.3 M to 5.3 M (+0.16 %)
Dec 30 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA28.3828,188799,975385,841357.7 K to 385.8 K (+7.88 %)
Dec 30 2016XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,0510106,184
Dec 30 2016XONINTREXON CORPKIRK RANDAL JDirectorGrantA0.0017,2040139,513122.3 K to 139.5 K (+14.07 %)
Dec 29 2016XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.4520,0779,035674,169694.2 K to 674.2 K (-2.89 %)
Dec 29 2016XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.4740,45019,012694,246734.7 K to 694.2 K (-5.51 %)
Dec 29 2016XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.5124,09212,287734,696758.8 K to 734.7 K (-3.18 %)
Dec 29 2016XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.4521,9239,865736,170758.1 K to 736.2 K (-2.89 %)
Dec 29 2016XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.4744,17020,760758,093802.3 K to 758.1 K (-5.51 %)
Dec 29 2016XONINTREXON CORPKIRK RANDAL J10% OwnerSellS0.5126,30813,417802,263828.6 K to 802.3 K (-3.18 %)
Dec 29 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerSellS0.4520,0779,035674,169694.2 K to 674.2 K (-2.89 %)
Dec 29 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerSellS0.4740,45019,012694,246734.7 K to 694.2 K (-5.51 %)
Dec 29 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerSellS0.5124,09212,287734,696758.8 K to 734.7 K (-3.18 %)
Dec 29 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerSellS0.4521,9239,865736,170758.1 K to 736.2 K (-2.89 %)
Dec 29 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerSellS0.4744,17020,760758,093802.3 K to 758.1 K (-5.51 %)
Dec 29 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerSellS0.5126,30813,417802,263828.6 K to 802.3 K (-3.18 %)
Dec 14 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyP28.9034,6061,000,113213,805179.2 K to 213.8 K (+19.31 %)
Dec 01 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0400105,133
Dec 01 2016XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,0400105,133
Dec 01 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA29.186,854200,0005,288,9805.3 M to 5.3 M (+0.13 %)
Dec 01 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA32.6624,494799,974357,653333.2 K to 357.7 K (+7.35 %)
Nov 16 2016XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseC0.002,142,85700
Nov 16 2016XONINTREXON CORPKIRK RANDAL J10% OwnerBuyC0.00428,5710828,571400 K to 828.6 K (+107.14 %)
Nov 16 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerOption ExerciseC0.002,142,85700
Nov 16 2016APHBAmpliPhi Bioscienc ...KIRK RANDAL J10% OwnerBuyC0.00428,5710828,571400 K to 828.6 K (+107.14 %)
Nov 02 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0300104,093
Nov 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA26.107,662199,9785,282,1265.3 M to 5.3 M (+0.15 %)
Nov 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA26.6829,985800,000333,159303.2 K to 333.2 K (+9.89 %)
Nov 02 2016XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,0300104,093
Oct 04 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA28.027,137199,9795,274,4645.3 M to 5.3 M (+0.14 %)
Oct 04 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA27.4429,154799,986303,174274 K to 303.2 K (+10.64 %)
Oct 04 2016XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseJ0.001,0200103,063
Oct 04 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0200103,063
Sep 09 2016XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseP1.502,604,3453,906,5182,604,345
Sep 09 2016XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseP1.503,913,9795,870,9693,913,979
Sep 09 2016XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseP1.507,32510,9887,325
Sep 09 2016XONINTREXON CORPKIRK RANDAL J10% OwnerOption ExerciseP1.50236,851355,277236,851
Sep 09 2016FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP1.502,604,3453,906,5182,604,345
Sep 09 2016FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP1.503,913,9795,870,9693,913,979
Sep 09 2016FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP1.507,32510,9887,325
Sep 09 2016FCSCFibrocell Science, ...KIRK RANDAL J10% OwnerOption ExerciseP1.50236,851355,277236,851
Sep 02 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0100102,043
Sep 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA25.247,923199,9775,267,3275.3 M to 5.3 M (+0.15 %)
Sep 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA29.0027,586799,994274,020246.4 K to 274 K (+11.19 %)
Aug 18 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...Option ExerciseX3.182,9579,4030
Aug 18 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...Option ExerciseX2.658,87123,5080
Aug 18 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyX3.182,9579,4035,259,4045.3 M to 5.3 M (+0.06 %)
Aug 18 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyX2.658,87123,5085,256,4475.2 M to 5.3 M (+0.17 %)
Aug 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA25.337,895199,9805,247,5765.2 M to 5.2 M (+0.15 %)
Aug 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA24.5532,586799,986246,434213.8 K to 246.4 K (+15.24 %)
Aug 02 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseJ0.001,0330101,033
Jul 06 2016XONINTREXON CORPKIRK RANDAL JDirectorOption ExerciseP0.00100,0000100,000
Jul 06 2016ZIOPZIOPHARM ONCOLOGY ...KIRK RANDAL JDirectorOption ExerciseP0.00100,0000100,000
Jul 05 2016XONINTREXON CORPKIRK RANDAL J10% OwnerBuyP0.522,261,4191,166,66614,481,08912.2 M to 14.5 M (+18.51 %)
Jul 05 2016OGENORAGENICS INCKIRK RANDAL J10% OwnerBuyP0.522,261,4191,166,66614,481,08912.2 M to 14.5 M (+18.51 %)
Jul 01 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA24.618,126199,9815,239,6815.2 M to 5.2 M (+0.16 %)
Jul 01 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...GrantA25.5031,372799,986213,848182.5 K to 213.8 K (+17.19 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0021,858021,8580 to 21.9 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0065,572065,5720 to 65.6 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.00131,1440131,1440 to 131.1 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.004,382046,70142.3 K to 46.7 K (+10.35 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0027,2600290,460263.2 K to 290.5 K (+10.36 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.002,23502,2350 to 2.2 K
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0023,2590354,653331.4 K to 354.7 K (+7.02 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0023,2590354,654331.4 K to 354.7 K (+7.02 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.009,9540302,954293 K to 303 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.009,9540302,954293 K to 303 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.009,9540302,954293 K to 303 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.00372011,31710.9 K to 11.3 K (+3.40 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.00371,18603,056,6012.7 M to 3.1 M (+13.82 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorBuyJ0.0081,7950216,795135 K to 216.8 K (+60.59 %)
Jun 02 2016GYHTHALOZYME THERAPEUT ...KIRK RANDAL JDirectorSellJ0.001,326,320001.3 M to 0 (-100.00 %)
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0019,711019,7110 to 19.7 K
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.0059,133059,1330 to 59.1 K
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.00118,2660118,2660 to 118.3 K
Jun 02 2016XONINTREXON CORPKIRK RANDAL JChief Executive Off ...BuyJ0.003,9520135,033131.1 K to 135 K (+3.01 %)

Page:   < prev 1 ... 2 3 4 5 6 next >